Literature DB >> 8404732

How common is catamenial epilepsy?

S Duncan1, C L Read, M J Brodie.   

Abstract

Forty women of childbearing age with refractory epilepsy were asked to record their seizures, the first and last days of their menstrual periods, and symptoms of premenstrual tension for 3 consecutive months. By defining catamenial epilepsy as the occurrence of at least 75% of seizures each month in the 10-day time frame, which included the 4 days preceding menstruation and the 6 days after its onset, only 5 women (12.5%) were identified who fulfilled the criterion. Nevertheless, after the study was completed, 31 (78%) of these patients claimed that most of their seizures occurred near the time of and were exacerbated by menstruation. The patients with catamenial epilepsy reported no more symptoms of premenstrual tension than did the rest of the group. Clustering outside the menstrual cycle was noted in 4 other patients. Catamenial epilepsy is an uncommon condition. Patient claims about frequency of seizures in relation to menstruation are not always accurate. A standard definition should be adopted because the diagnosis has implications for management.

Entities:  

Mesh:

Year:  1993        PMID: 8404732     DOI: 10.1111/j.1528-1157.1993.tb02097.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  19 in total

Review 1.  Teenagers with epilepsy.

Authors:  R E Appleton; B G Neville
Journal:  Arch Dis Child       Date:  1999-07       Impact factor: 3.791

2.  Lacosamide for epileptic seizures in patients with co-morbidities and unusual presentations of epilepsy.

Authors:  Alba Sierra-Marcos; Pedro Emilio Bermejo; Raquel Manso Calderón; Angela María Gutiérrez-Álvarez; Catalina Jiménez Corral; Daniel Sagarra Mur
Journal:  CNS Drugs       Date:  2011-12-05       Impact factor: 5.749

Review 3.  The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female.

Authors:  Helen E Scharfman; Neil J MacLusky
Journal:  Epilepsia       Date:  2006-09       Impact factor: 5.864

4.  Women and epilepsy.

Authors:  Sunila E O'Connor; Mary L Zupanc
Journal:  J Pediatr Pharmacol Ther       Date:  2009-10

Review 5.  Neuroendocrine considerations in the treatment of men and women with epilepsy.

Authors:  Cynthia L Harden; Page B Pennell
Journal:  Lancet Neurol       Date:  2013-01       Impact factor: 44.182

Review 6.  Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations.

Authors:  James W McAuley; Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 7.  Managing epilepsy in women of childbearing age.

Authors:  Pamela M Crawford
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 8.  The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy.

Authors:  Doodipala Samba Reddy
Journal:  Epilepsy Res       Date:  2009-04-29       Impact factor: 3.045

Review 9.  Hormonal aspects of epilepsy.

Authors:  Page B Pennell
Journal:  Neurol Clin       Date:  2009-11       Impact factor: 3.806

10.  Seizing an opportunity: broader definitions of epilepsy may lead to better treatments.

Authors:  Helen E Scharfman
Journal:  Cerebrum       Date:  2010-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.